Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

by Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won Young Tak, Xiaoping Yu, Joon Hyeok Lee, Shi Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart, Jian Hua Wang
Published 2018